Document is current

Article History

Received: 24 April 2025

Accepted: 4 June 2025

First Online: 8 July 2025

Declarations

:

: Rachel Dawson,, David P. Greenberg, Helay Hassas, Heather Entenmann, and Maureen P. Neary are employees of Sanofi Vaccines US and Angie Upegui, and Corwin A. Robertson are employees of Sanofi Vaccines Global and may hold shares and/or stock options in the company. Katherine Galarza is a former employee of Sanofi Vaccines US. Sayali Nerurkar, Evan Jones Mann, and Liga Bennetts are employees of Amaris Consulting, which received professional fees from Sanofi for the study. Todd Wolynn has received consulting fees from Moderna, Pfizer, Merck, and Seqirus, payment or honoraria for lectures, presentations, speakers, bureaus, manuscript writing, or educational events from Moderna, and support for attending meetings and/or travel from Moderna, Sanofi, and Seqirus. John B. Grimes or his corporation Cemblem, LLC have received grants or contracts and consulting fees from GSK and Convatec, payment or honoraria for lectures, presentations, speakers, bureaus, manuscript writing, or educational events from Sanofi and IQVIA, and support for attending meetings and/or travel from GSK. He has participated in an advisory board for GSK and has a leadership or fiduciary role in the Confederation of Meningitis Organizations (Board Member) and Shots 4 Meningitis (Executive Director). Neither Todd Wolynn or John B. Grimes received compensation from Sanofi for this manuscript.

: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.